SFXN5: A Potential Drug Target and Biomarker (G94097)

Target Name: SFXN5

NCBI ID: G94097

SFXN5

SFXN5: A Potential Drug Target and Biomarker

Sideroflexin-5 (ISOform 2) is a protein that is expressed in various tissues of the body, including the liver, spleen, and peripheral blood cells. It is a member of the sideroflexin family of proteins, which are involved in the regulation of cell signaling pathways. One of the unique features of sideroflexin-5 is its ability to interact with and modulate the activity of several different signaling pathways, including those involved in cell growth, differentiation, and inflammation.

Several studies have suggested that sideroflexin-5 may have potential as a drug target or biomarker. One potential mechanism by which sideroflexin-5 could be targeted is by its ability to interact with and modulate the activity of the TGF-β pathway. The TGF-β pathway is a well-established pathway that is involved in the regulation of cell growth, differentiation, and inflammation. It is a potential target for a variety of drugs, including anti-cancer drugs, because of its central role in the regulation of cell signaling pathways.

Sideroflexin-5 has been shown to interact with and modulate the activity of TGF-β1, TGF-β2, and TGF-β3, all of which are critical components of the TGF-β pathway. These interactions suggest that sideroflexin-5 may be a useful drug target or biomarker for the TGF-β pathway.

Another potential mechanism by which sideroflexin-5 could be used as a drug target is its ability to interact with and modulate the activity of the NF-kappa-B pathway. The NF-kappa-B pathway is a signaling pathway that is involved in the regulation of inflammation and immune responses. It is a potential target for a variety of drugs, including anti-inflammatory drugs, because of its central role in the regulation of cell signaling pathways.

Sideroflexin-5 has been shown to interact with and modulate the activity of NF-kappa-B1, NF-kappa-B2, and NF-kappa-B3, all of which are critical components of the NF-kappa-B pathway. These interactions suggest that sideroflexin-5 may be a useful drug target or biomarker for the NF-kappa-B pathway.

In addition to its potential as a drug target or biomarker, sideroflexin-5 also has potential as a diagnostic biomarker. Several studies have shown that sideroflexin-5 is expressed in a variety of tissues and cells, including liver, spleen, and peripheral blood cells. This suggests that it may be a useful biomarker for a variety of diseases, including liver disease, cancer, and autoimmune disorders.

Furthermore, there is increasing interest in using sideroflexin-5 as a diagnostic tool for the study of chronic diseases. Several studies have shown that sideroflexin-5 is expressed in the liver, spleen, and peripheral blood cells of individuals with a variety of chronic diseases, including diabetes, heart disease, and autoimmune disorders. This suggests that sideroflexin-5 may be a useful diagnostic tool for the study of these diseases.

Overall, sideroflexin-5 is a protein that has potential as a drug target or biomarker. Its ability to interact with and modulate the activity of multiple signaling pathways, including TGF-β and NF-kappa-B, suggests that it may be a useful target for a variety of drugs, including anti-cancer and anti-inflammatory drugs. Its ability to interact with and modulate the activity of multiple tissues and cells also suggests that it may be a useful diagnostic tool for the study of a variety of chronic diseases. Further research is needed to fully understand the potential of sideroflexin-5 as a drug target or biomarker.

Protein Name: Sideroflexin 5

Functions: Mitochondrial amino-acid transporter (By similarity). Transports citrate (By similarity). Does not act as a serine transporter: not able to mediate transport of serine into mitochondria (PubMed:30442778) (By similarity). In brown adipose tissue, plays a role in the regulation of UCP1-dependent thermogenesis probably by supporting mitochondrial glycerol-3-phosphate utilization (By similarity)

The "SFXN5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SFXN5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets